Table 1.

Baseline Characteristics by Study Group

Characteristic	Bariatric Surgery LAGB	IMWM (Why WAIT)
Age, y	50.6 ± 12.6	51.4 ± 7.5
Gender (male/female), n	9/9	13/9
Race and ethnicity
Caucasian	11 (61)	13 (59)
African American	6 (33)	8 (36)
Asian	1 (6)	0 (0)
Multiracial	0 (0)	1 (5)
Hispanica	0 (0)	4 (18)
BMI, kg/m2	36.4 ± 3.0	36.7 ± 4.2
Subjects with BMI < 35 kg/m2	7 (39)	8 (36)
Weight, kg	106.8 ± 10.4	111.6 ± 17.9
Systolic blood pressure, mm Hg	129 ± 7	126 ± 13
Diastolic blood pressure, mm Hg	79 ± 5	81 ± 8
Years since diagnosis	10.4 ± 5.6	8.4 ± 4.2
History of retinopathy	1 (6)	0 (0)
History of neuropathy	1 (6)	5 (23)
History of nephropathy	1 (6)	0 (0)
Insulin	13 (72)	4 (18)
Metformin	13 (72)	18 (82)
GLP-1 agonists	5 (28)	7 (32)
Symlin	1 (6)	0 (0)
Other glycemic medications	2 (11)	10 (45)
Statin	14 (78)	15 (68)
Other lipid-lowering medications	4 (22)	1 (5)
ACE inhibitor/ARB	11 (61)	14 (64)
Other antihypertensive medications	9 (50)	9 (41)
HbA1c, mmol/mol	68.4 ± 12.1	64.8 ± 13.4
HbA1c, %	8.4 ± 1.1	8.1 ± 1.2
Glucose, mmol/L	9.27 ± 3.55	8.60 ± 2.66
Glucose, mg/dL	167 ± 64	155 ± 48
Total cholesterol, mmol/L	4.01 ± 0.88	4.17 ± 0.75
Total cholesterol, mg/dL	155 ± 34	161 ± 29
Triglyceride, mmol/L	1.99 ± 1.34	1.64 ± 1.18
Triglyceride, mg/dL	176 ± 119	145 ± 104
HDL, mmol/L	0.96 ± 0.23	1.09 ± 0.31
HDL, mg/dL	37 ± 9	42 ± 12
LDL, mmol/Lb	2.38 ± 0.70	2.36 ± 0.70
LDL, mg/dL	92 ± 27	91 ± 27
UKPDS risk scores
Coronary heart disease risk	10.5 ± 7.8	9.7 ± 8.1
Fatal coronary heart disease risk	6.5 ± 5.4	5.8 ± 5.3
Stroke risk	4.5 ± 3.4	3.7 ± 2.6
Fatal stroke risk	0.6 ± 0.5	0.5 ± 0.4

Data are expressed as mean ± SD or number (percentage). Laboratory assessments were made after an overnight fast. GLP-1, glucagon-like peptide-1; ACE, angiotensin converting enzyme; ARB, angiotensin receptor blocker; UKPDS, United Kingdom Prospective Diabetes Study.

^aHispanic may be of any race.

^bLDL measured directly.